Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 14Gastrointestinal 7Other hematologic neoplasm 4Thoracic 3Myeloid 2Lymphoid 2CNS 2Tumor-Agnostic 1Plasma cell 1Other neoplasm 1Classical hematology 1Breast 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Induction Chemotherapy × Thoracic × Clear all
NCT06484491 2026-01-30

HyDose

University Medical Center Groningen

Phase NA Recruiting
87 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01850303 2023-03-14

MODEL

Intergroupe Francophone de Cancerologie Thoracique

Phase 3 Completed
632 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02054819 2019-08-21

Treating NSCLC Minimal Stage IV With Curative Intent

Leo W. Jenkins Cancer Center

Phase 2 Terminated
14 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡